Industry News

Global biosimilars market expected to reach $35 billion by 2020

Centerwatch - Mon, 2014-07-21 11:23
A new report by Allied Market Research (AMR), Global biosimilars/follow-on-biologics market (types, applications and geography)--Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020, suggests the global biosimilars market could reach $35 billion by 2020 from the estimated $1.3 billion in 2013.
Categories: Industry News

Accovion continues expansion of European presence

Centerwatch - Mon, 2014-07-21 11:14
Germany-based CRO Accovion has expanded its European presence. The company, already active in more than 20 countries, has established a subsidiary in Milan, Italy, naming Verónica de Lázaro country director.
Categories: Industry News

E-clinical software market expected to reach $6.52 billion by 2020

Centerwatch - Mon, 2014-07-21 11:08
According to a new market report published by Transparency Market Research (TMR), E-Clinical Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020, the e-clinical solution software market, valued at $3 billion in 2014, is expected to grow at a CAGR of 13.8% from 2014 to 2020 to reach an estimated value of $6.52 billion in 2020.
Categories: Industry News

GVK Bio launches new clinical development service offering

Centerwatch - Mon, 2014-07-21 11:06
India-based GVK Biosciences has unveiled a new brand, Clinogent, in the clinical development industry. Clinogent provides end-to-end clinical development services, from bioequivalence studies for generic pharma to late phase patient-based clinical studies. It offers solutions to complex data analysis and medical communication problems.
Categories: Industry News

AstraZeneca reveals designs for new U.K. global R&D center, corporate headquarters

Centerwatch - Mon, 2014-07-21 11:03
AstraZeneca revealed its proposed designs for its new global R&D center and corporate headquarters in Cambridge, U.K. The facility, which will be located on the Cambridge Biomedical Campus (CBC), includes the global center, an R&D enabling building and an energy center.
Categories: Industry News

Evidera appoints Xavier Badia senior research and market development leader

Centerwatch - Mon, 2014-07-21 04:03
Evidera, a global provider of health economics, outcomes research, market access, data analytics and epidemiology solutions, has announced the addition of Xavier Badia, M.D., M.P.H., Ph.D. Badia will be senior research leader and senior leader of market development for the growing Evidera team in Europe.
Categories: Industry News

Dipexium Pharmaceuticals initiates phase III trial for diabetic foot ulcer infections

Centerwatch - Mon, 2014-07-21 04:00
Dipexium Pharmaceuticals has initiated patient enrollment in the first of two pivotal phase III clinical trials, known as OneStep-1 and OneStep-2, evaluating Locilex (pexiganan cream 0.8%), the company's novel, broad-spectrum, topical antibiotic peptide, for the treatment of patients with mild infections of diabetic foot ulcers, or Mild DFI.
Categories: Industry News

The Pulse on Study Conduct

Centerwatch - Mon, 2014-07-21 03:00
Investigative site logistics and core business models vary dramatically.
Categories: Industry News

A Study of Gantenerumab in Patients With Mild Alzheimer Disease

Alzheimers - Sun, 2014-07-20 20:00
Status: Recruiting, Condition Summary: Alzheimer Disease
Categories: Industry News

Additions/Deletions for Prescription and OTC Drug Product Lists

FDA News - Fri, 2014-07-18 11:31
The list has been updated through June 2014.
Categories: Industry News

Comunicado de la FDA sobre la seguridad de los medicamentos: Estudio de la FDA de pacientes de Medicare encontró menor riesgo de derrame cerebral y muerte con Pradaxa (dabigatrán) en comparación con warfarina

FDA News - Fri, 2014-07-18 09:51
[05-13-2014] En su estudio en curso del anticoagulante Pradaxa (dabigatrán), la Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus sigla en inglés) completó recientemente un nuevo estudio en pacientes de Medicare en el que compara Pradaxa con un anticoagulante antiguo, warfarina (Coumadin, Jantoven y genéricos), para determinar el riesgo de accidente isquémico o derrame causado por un coágulo, hemorragia cerebral, hemorragia gastrointestinal severa, infarto de miocardio y muerte.
Categories: Industry News

Kirby Institute comments on death of Professor Joep Lange in Malaysia Airlines attack

Centerwatch - Fri, 2014-07-18 09:39
The Kirby Institute at the University of New South Wales (UNSW) Australia has lost longtime colleague, professor Joep Lange, who was among the almost three hundred people on Malaysian Airlines flight MH17 shot down on the Russian-Ukraine border.
Categories: Industry News

AHRQ awards $2.5M grant to establish patient-centered outcomes research training program

Centerwatch - Fri, 2014-07-18 09:34
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $2.5 million grant from the Agency for Healthcare Research and Quality (AHRQ) to establish a training program to improve the practice of healthcare in real-world settings.
Categories: Industry News

TrialNetworks adds visual intelligence to clinical trial optimization system

Centerwatch - Fri, 2014-07-18 09:33
The Clinical Trial Optimization System from TrialNetworks, now part of DrugDev, has launched its latest app, TrialNetworks Charting. TrialNetworks Charting provides sponsors and CROs with visual intelligence into the study’s progress toward goals by region, country and site.
Categories: Industry News

Myos, Cloud Pharmaceuticals ink agreement

Centerwatch - Fri, 2014-07-18 09:32
Myos, a biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, has entered into an R&D agreement with Cloud Pharmaceuticals.
Categories: Industry News

FDA Drug Safety Communication: FDA warns that cancer drug docetaxel may cause symptoms of alcohol intoxication after treatment

FDA News - Fri, 2014-07-18 09:14
[6-20-2014] The U.S. Food and Drug Administration (FDA) is warning that the intravenous chemotherapy drug docetaxel contains ethanol, also known as alcohol, which may cause patients to experience intoxication or feel drunk during and after treatment.
Categories: Industry News

Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA recomienda no usar lidocaína para el tratamiento del dolor por dentición y requiere nuevo Recuadro de advertencia

FDA News - Fri, 2014-07-18 07:58
[6-26-2014] La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por su sigla en inglés) advirtió que la solución de lidocaína viscosa al 2 por ciento para uso oral y de venta con receta médica, no se debe usar en el tratamiento del dolor por dentición de bebés o niños.
Categories: Industry News

FDA Drug Safety Communication: FDA recommends not using lidocaine to treat teething pain and requires new Boxed Warning

FDA News - Fri, 2014-07-18 07:47
[6-XX-2014] The U.S. Food and Drug Administration (FDA) warns that prescription oral viscous lidocaine 2 percent solution should not be used to treat infants and children with teething pain.
Categories: Industry News

AbbVie to acquire Shire in $54.6 billion deal

Centerwatch - Fri, 2014-07-18 06:24
The boards of AbbVie and Shire have reached agreement on the terms of a recommended combination of Shire with AbbVie that values Shire at approximately $54.61 billion.
Categories: Industry News

Multimodal Therapy for Sleep Disturbances

sleep - Thu, 2014-07-17 20:00
Status: Recruiting, Condition Summary: Advanced Cancers
Categories: Industry News
Syndicate content